Different experiments on the use of BoNT during the management of different suffering Problems are listed in Table 3. On August 2, 2010, the US FDA announced the approval of incobotulinumtoxinA (Xeomin®) with the treatment of Grownups with cervical dystonia, to lower the severity of irregular head placement and neck pain in both equally bot